Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
As of close of business last night, Taysha Gene Therapies Inc’s stock clocked out at $2.53, down -1.56% from its previous closing price of $2.57. In other words, the price has decreased by -$1.56 from its previous closing price. On the day, 2.32 million shares were traded. TSHA stock price reached its highest trading level at $2.675 during the session, while it also had its lowest trading level at $2.47.
Ratios:
To gain a deeper understanding of TSHA’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.35 and its Current Ratio is at 5.35. In the meantime, Its Debt-to-Equity ratio is 1.13 whereas as Long-Term Debt/Eq ratio is at 1.09.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, BofA Securities on July 11, 2025, initiated with a Buy rating and assigned the stock a target price of $8.
On June 27, 2024, BMO Capital Markets started tracking the stock assigning a Outperform rating and target price of $5.
On April 09, 2024, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $9.Piper Sandler initiated its Overweight rating on April 09, 2024, with a $9 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on May 30 ’25 when Manning Paul B bought 750,000 shares for $2.75 per share. The transaction valued at 2,062,500 led to the insider holds 2,841,704 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TSHA now has a Market Capitalization of 661670912 and an Enterprise Value of 440904576. For the stock, the TTM Price-to-Sale (P/S) ratio is 91.64 while its Price-to-Book (P/B) ratio in mrq is 9.42. Its current Enterprise Value per Revenue stands at 61.033 whereas that against EBITDA is -5.344.
Stock Price History:
The Beta on a monthly basis for TSHA is 0.95, which has changed by 0.17889905 over the last 52 weeks, in comparison to a change of 0.13161862 over the same period for the S&P500. Over the past 52 weeks, TSHA has reached a high of $3.31, while it has fallen to a 52-week low of $1.05. The 50-Day Moving Average of the stock is -1.33%, while the 200-Day Moving Average is calculated to be 25.59%.
Shares Statistics:
It appears that TSHA traded 3.91M shares on average per day over the past three months and 2847680 shares per day over the past ten days. A total of 261.53M shares are outstanding, with a floating share count of 213.39M. Insiders hold about 18.41% of the company’s shares, while institutions hold 66.24% stake in the company. Shares short for TSHA as of 1749772800 were 33272908 with a Short Ratio of 10.19, compared to 1747267200 on 26236920. Therefore, it implies a Short% of Shares Outstanding of 33272908 and a Short% of Float of 14.29.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
